Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):215–221. doi: 10.1097/MPG.0b013e3182a98df2

Figure 5.

Figure 5

Incidence of infliximab failure (A) and infliximab dose escalation (B) in patients started on infliximab monotherapy versus those started on infliximab with a concomitant immunomodulator (thiopurine or methotrexate).